FDA OK’s Biogen’s Alzheimer’s drug: What is Accelerated Approval?

The Food and Drug Administration on Monday approved Biogen’s Alzheimer’s drug albeit to mixed reviews. In announcing its decision, the agency noted that the drug was granted “Accelerated Approval,” which…

How will insurers cover Biogen’s new Alzheimer’s drug?

T3 Trading chief strategist Scott Redler gives his market outlook on biotech investing. Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients…

FDA approval of Biogen’s Alzheimer’s drug leaves some ‘disappointed’

WASHINGTON – Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been…

FDA approves Biogen’s Alzheimer’s drug

Alzheimer’s treatment revival The Food and Drug Administration (FDA) on Monday approved Biogen’s Alzheimer’s drug, marking the first new authorized therapy to treat the disease in nearly two decades. The…